{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T20:57:22Z","timestamp":1783976242615,"version":"3.55.0"},"reference-count":223,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.cgh.2015.08.012","type":"journal-article","created":{"date-parts":[[2015,8,15]],"date-time":"2015-08-15T14:17:52Z","timestamp":1439648272000},"page":"2088-2108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Autoimmune Hepatitis and Overlap Syndromes: Diagnosis and Management"],"prefix":"10.1016","volume":"13","author":[{"given":"John M.","family":"Vierling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2015.08.012_bib1","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2015.08.012_bib2","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0140-6736(12)62163-1","article-title":"Autoimmune hepatitis","volume":"382","author":"Heneghan","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2015.08.012_bib3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11684-015-0386-y","article-title":"Autoimmune hepatitis","volume":"9","author":"Sahebjam","year":"2015","journal-title":"Front Med"},{"key":"10.1016\/j.cgh.2015.08.012_bib4","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.bpg.2011.09.009","article-title":"Pathogenesis of autoimmune hepatitis","volume":"25","author":"Liberal","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib5","series-title":"Autoimmune hepatitis: a guide for practicing clinicians","first-page":"3","article-title":"The pathogenesis of autoimmune hepatitis","author":"Vierling","year":"2012"},{"key":"10.1016\/j.cgh.2015.08.012_bib6","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.jhep.2015.03.005","article-title":"Autoimmune hepatitis: update 2015","volume":"62","author":"Manns","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","article-title":"Diagnosis and treatment of autoimmune hepatitis","volume":"36","author":"Czaja","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2015.08.012_bib8","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1440-1746.2010.06384.x","article-title":"Population-based epidemiology study of autoimmune hepatitis: a disease of older women?","volume":"25","author":"Ngu","year":"2010","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.510250308","article-title":"Autoimmune hepatitis in childhood: a 20-year experience","volume":"25","author":"Gregorio","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2015.08.012_bib10","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S1089-3261(02)00021-1","article-title":"Prevalence and epidemiology of autoimmune hepatitis","volume":"6","author":"Boberg","year":"2002","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cgh.2015.08.012_bib11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1155\/2013\/198070","article-title":"Diagnosis and management of the overlap syndromes of autoimmune hepatitis","volume":"27","author":"Czaja","year":"2013","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib12","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib13","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2015.08.012_bib15","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","article-title":"Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis","volume":"139","author":"Manns","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2015.08.012_bib16","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bpg.2011.09.008","article-title":"Liver transplantation in autoimmune liver diseases","volume":"25","author":"Ilyas","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib17","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.autrev.2013.11.009","article-title":"Diagnostic criteria of autoimmune hepatitis","volume":"13","author":"Liberal","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cgh.2015.08.012_bib18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/hep.24080","article-title":"Autoimmune acute liver failure: proposed clinical and histological criteria","volume":"53","author":"Stravitz","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2015.08.012_bib19","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/hepr.12031","article-title":"Acute presentation of autoimmune hepatitis: how to find and manage still remains unsolved","volume":"43","author":"Tanaka","year":"2013","journal-title":"Hepatol Res"},{"key":"10.1016\/j.cgh.2015.08.012_bib20","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s10620-012-2445-4","article-title":"Acute and acute severe (fulminant) autoimmune hepatitis","volume":"58","author":"Czaja","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2015.08.012_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11894-011-0236-2","article-title":"Diagnosis and treatment of autoimmune hepatitis","volume":"14","author":"Vierling","year":"2012","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.cgh.2015.08.012_bib22","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0016-5085(78)90238-X","article-title":"Wilson's disease, presenting as chronic active hepatitis","volume":"74","author":"Scott","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2015.08.012_bib23","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1046\/j.1440-1746.2000.02158.x","article-title":"Wilson's disease with superimposed autoimmune features: report of two cases and review","volume":"15","author":"Milkiewicz","year":"2000","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib24","doi-asserted-by":"crossref","first-page":"e7872","DOI":"10.5812\/hepatmon.7872","article-title":"Autoimmune hepatitis or Wilson's disease, a clinical dilemma","volume":"13","author":"Deutsch","year":"2013","journal-title":"Hepat Mon"},{"key":"10.1016\/j.cgh.2015.08.012_bib25","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1399-3046.2005.00254.x","article-title":"Fulminant hepatic failure: Wilson's disease or autoimmune hepatitis? implications for transplantation","volume":"9","author":"Santos","year":"2005","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.cgh.2015.08.012_bib26","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1053\/j.gastro.2011.02.010","article-title":"Comparability of probable and definite autoimmune hepatitis by international diagnostic scoring criteria","volume":"140","author":"Czaja","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2015.08.012_bib27","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.dld.2010.03.005","article-title":"Comparison of simplified score with the revised original score for the diagnosis of autoimmune hepatitis: a new or a complementary diagnostic score?","volume":"42","author":"Gatselis","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2015.08.012_bib28","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.3748\/wjg.v19.i23.3629","article-title":"Role of international criteria in the diagnosis of autoimmune hepatitis","volume":"19","author":"Abdollahi","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3892\/etm.2013.1366","article-title":"Evaluation of the revised versus the simplified scoring system in patients with autoimmune hepatitis","volume":"7","author":"Li","year":"2014","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.cgh.2015.08.012_bib30","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jhep.2010.06.032","article-title":"Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients","volume":"54","author":"Qiu","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib31","first-page":"326","article-title":"The overlap syndromes of autoimmune hepatitis","volume":"58","author":"Czaja","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2015.08.012_bib32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000347211","article-title":"Autoimmune hepatitis","volume":"31","author":"Strassburg","year":"2013","journal-title":"Dig Dis"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2015.08.012_bib33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00535-010-0324-3","article-title":"Discrimination of autoimmune hepatitis: autoantibody typing and beyond","volume":"46","author":"Krawitt","year":"2011","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib34","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/hep.26666","article-title":"Antismooth muscle and antiactin antibodies are indirect markers of histological and biochemical activity of autoimmune hepatitis","volume":"59","author":"Couto","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2015.08.012_bib35","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s10620-011-2017-z","article-title":"Autoantibody-negative autoimmune hepatitis","volume":"57","author":"Czaja","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2015.08.012_bib36","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10620-010-1501-1","article-title":"Performance parameters of the conventional serological markers for autoimmune hepatitis","volume":"56","author":"Czaja","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2015.08.012_bib37","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group","volume":"41","author":"Vergani","year":"2004","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib38","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jaut.2010.09.005","article-title":"PBC screen: an IgG\/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis","volume":"35","author":"Liu","year":"2010","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.cgh.2015.08.012_bib39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2009.08.010","article-title":"Aetiopathogenesis of autoimmune hepatitis","volume":"34","author":"Longhi","year":"2010","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.cgh.2015.08.012_bib40","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1007\/s10620-010-1268-4","article-title":"Autoantibodies as prognostic markers in autoimmune liver disease","volume":"55","author":"Czaja","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2015.08.012_bib41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1478-3231.2011.02502.x","article-title":"Prognostic implications of antibodies to Ro\/SSA and soluble liver antigen in type 1 autoimmune hepatitis","volume":"32","author":"Montano-Loza","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2015.08.012_bib42","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1572-0241.2006.00479.x","article-title":"Pregnancy in autoimmune hepatitis: outcome and risk factors","volume":"101","author":"Schramm","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib43","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.cld.2010.07.003","article-title":"Histology of autoimmune hepatitis and its variants","volume":"14","author":"Guindi","year":"2010","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cgh.2015.08.012_bib44","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3109\/00365521.2013.772231","article-title":"Diagnostic difficulties, therapeutic strategies, and performance of scoring systems in patients with autoimmune hepatitis and concurrent hepatitis B\/C","volume":"48","author":"Efe","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib45","doi-asserted-by":"crossref","first-page":"e85330","DOI":"10.1371\/journal.pone.0085330","article-title":"Increased HEV seroprevalence in patients with autoimmune hepatitis","volume":"9","author":"Pischke","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2015.08.012_bib46","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3350\/cmh.2012.18.2.213","article-title":"The clinical features of drug-induced liver injury observed through liver biopsy: focus on relevancy to autoimmune hepatitis","volume":"18","author":"Ju","year":"2012","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib47","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.3748\/wjg.v20.i13.3597","article-title":"Clinicopathological study of primary biliary cirrhosis with interface hepatitis compared to autoimmune hepatitis","volume":"20","author":"Kobayashi","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib48","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/gut.41.2.269","article-title":"Autoimmune hepatitis: a histological variant associated with prominent centrilobular necrosis","volume":"41","author":"Te","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2015.08.012_bib49","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/jcp.2005.029348","article-title":"Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation","volume":"59","author":"Hofer","year":"2006","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.cgh.2015.08.012_bib50","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cgh.2010.07.016","article-title":"Patients with typical laboratory features of autoimmune hepatitis rarely need a liver biopsy for diagnosis","volume":"9","author":"Bjornsson","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib51","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.cgh.2013.08.039","article-title":"Cholestatic phenotypes of autoimmune hepatitis","volume":"12","author":"Czaja","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib52","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jhep.2005.11.037","article-title":"Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a foray across diagnostic boundaries","volume":"44","author":"Czaja","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198301063080101","article-title":"The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis","volume":"308","author":"Roll","year":"1983","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2015.08.012_bib54","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/0016-5085(85)90213-6","article-title":"Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis: final results of an international trial","volume":"89","author":"Christensen","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2015.08.012_bib55","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0168-8278(92)90065-W","article-title":"A\u00a0controlled trial of prednisolone treatment in primary biliary cirrhosis: three-year results","volume":"15","author":"Mitchison","year":"1992","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib56","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJM199005173222003","article-title":"A\u00a0controlled trial of cyclosporine in the treatment of primary biliary cirrhosis","volume":"322","author":"Wiesner","year":"1990","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2015.08.012_bib57","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0016-5085(76)80250-8","article-title":"A\u00a0prospective controlled trial of azathioprine in primary biliary cirrhosis","volume":"70","author":"Heathcote","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2015.08.012_bib58","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouilleres","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2015.08.012_bib59","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.cgh.2010.03.004","article-title":"Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome","volume":"8","author":"Kuiper","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib60","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/j.1478-3231.2007.01538.x","article-title":"Development of autoimmune hepatitis in primary biliary cirrhosis","volume":"27","author":"Gossard","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2015.08.012_bib61","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1440-1746.2009.06018.x","article-title":"Overlap of primary biliary cirrhosis and autoimmune hepatitis: characteristics, therapy, and long term outcomes","volume":"25","author":"Yokokawa","year":"2010","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib62","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0399-8320(07)89323-7","article-title":"Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease","volume":"31","author":"Heurgue","year":"2007","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.cgh.2015.08.012_bib63","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1572-0241.2007.01136.x","article-title":"Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes","volume":"102","author":"Silveira","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib64","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/MEG.0b013e328350f95b","article-title":"Autoimmune hepatitis\/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases","volume":"24","author":"Efe","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib65","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1665-2681(19)31583-2","article-title":"Does HLA-DR7 differentiate the overlap syndrome of auto-immune hepatitis-primary biliary cirrhosis (AIH-PBC) from those with auto-immune hepatitis type 1?","volume":"10","author":"Coss","year":"2011","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib66","article-title":"Hispanics with primary biliary cirrhosis are more likely to have features of autoimmune hepatitis and reduced response to ursodeoxycholic acid than non-Hispanics","author":"Levy","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib67","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1309\/AJCPE93GZSHUNTAI","volume":"133","author":"Lee","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cgh.2015.08.012_bib68","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.dld.2009.12.006","article-title":"Intrahepatic IgG\/IgM plasma cells ratio helps in classifying autoimmune liver diseases","volume":"42","author":"Cabibi","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2015.08.012_bib69","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0168-8278(00)80004-5","article-title":"Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system","volume":"33","author":"Kaya","year":"2000","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib70","first-page":"15","article-title":"Evaluating distinctive features for early diagnosis of primary sclerosing cholangitis overlap syndrome in adults with autoimmune hepatitis","volume":"80","author":"Hunter","year":"2011","journal-title":"Ulster Med J"},{"key":"10.1016\/j.cgh.2015.08.012_bib71","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1572-0241.2005.41841.x","article-title":"Clinical course and outcome of autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome","volume":"100","author":"Floreani","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib72","first-page":"441","article-title":"Therapy response and outcome of overlap syndromes: autoimmune hepatitis and primary biliary cirrhosis compared to autoimmune hepatitis and autoimmune cholangitis","volume":"57","author":"Ozaslan","year":"2010","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.cgh.2015.08.012_bib73","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11894-999-0089-0","article-title":"Variant forms of autoimmune hepatitis","volume":"1","author":"Czaja","year":"1999","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.cgh.2015.08.012_bib74","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/apt.12381","article-title":"Review article: the management of autoimmune hepatitis beyond consensus guidelines","volume":"38","author":"Czaja","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2015.08.012_bib75","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1365-2036.2011.04658.x","article-title":"Systematic review: management options for primary sclerosing cholangitis and its variant forms\u2014IgG4-associated cholangitis and overlap with autoimmune hepatitis","volume":"33","author":"Culver","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2015.08.012_bib76","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00535-010-0323-4","article-title":"Clinical significance of immunoglobulin G4-associated autoimmune hepatitis","volume":"46","author":"Umemura","year":"2011","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib77","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.24481","article-title":"The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury","volume":"54","author":"Suzuki","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2015.08.012_bib78","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jhep.2010.12.041","article-title":"Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis","volume":"55","author":"Lucena","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib79","first-page":"123","article-title":"Drug-induced hepatitis, drug-induced autoimmunity or classical autoimmune hepatitis: how can we differentiate?","volume":"15","author":"Kaymakoglu","year":"2004","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib80","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/hep.24768","article-title":"Histological discrimination between autoimmune hepatitis and drug-induced liver injury","volume":"55","author":"Fujiwara","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2015.08.012_bib81","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s10620-011-1611-4","article-title":"Drug-induced autoimmune-like hepatitis","volume":"56","author":"Czaja","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2015.08.012_bib82","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.23588","article-title":"Drug-induced autoimmune hepatitis: clinical characteristics and prognosis","volume":"51","author":"Bjornsson","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2015.08.012_bib83","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/clpt.2011.58","article-title":"Case definition and phenotype standardization in drug-induced liver injury","volume":"89","author":"Aithal","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cgh.2015.08.012_bib84","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1023\/B:DDAS.0000004522.36120.08","article-title":"Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates","volume":"48","author":"Loria","year":"2003","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2015.08.012_bib85","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/01.mcg.0000139072.38580.a0","article-title":"Prevalence and significance of autoantibodies in patients with non-alcoholic steatohepatitis","volume":"38","author":"Cotler","year":"2004","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib86","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.3748\/wjg.v16.i29.3704","article-title":"Is autoimmune hepatitis a frequent finding among HCV patients with intense\u00a0interface hepatitis?","volume":"16","author":"Badiani","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib87","doi-asserted-by":"crossref","first-page":"e16089","DOI":"10.5812\/hepatmon.16089","article-title":"Occult hepatitis C virus infection in patients with autoimmune hepatitis","volume":"14","author":"Rezaee Zavareh","year":"2014","journal-title":"Hepat Mon"},{"key":"10.1016\/j.cgh.2015.08.012_bib88","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/lt.23764","article-title":"Hepatitis E infection in liver transplant recipients","volume":"20","author":"Unzueta","year":"2014","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2015.08.012_bib89","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/jmv.23469","article-title":"Infection with hepatitis E virus in kidney transplant recipients in southeastern France","volume":"85","author":"Moal","year":"2013","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.cgh.2015.08.012_bib90","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s00535-010-0316-3","article-title":"Clinicopathological features of severe and fulminant forms of autoimmune hepatitis","volume":"46","author":"Yasui","year":"2011","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib91","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000171594","article-title":"Extrahepatic immunologic features of chronic viral hepatitis","volume":"15","author":"Czaja","year":"1997","journal-title":"Dig Dis"},{"key":"10.1016\/j.cgh.2015.08.012_bib92","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1007\/s10620-009-0996-9","article-title":"The development of autoimmune hepatitis and primary biliary cirrhosis overlap syndrome during the course of connective tissue diseases: report of three cases and review of the literature","volume":"55","author":"Efe","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2015.08.012_bib93","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2015.08.012_bib94","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/hep.25869","article-title":"Screening for hepatocellular carcinoma: the rationale for the American Association for the Study of Liver Diseases recommendations","volume":"56","author":"Sherman","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2015.08.012_bib95","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s10620-012-2525-5","article-title":"Hepatocellular carcinoma and other malignancies in autoimmune hepatitis","volume":"58","author":"Czaja","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2015.08.012_bib96","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/00365521.2014.983154","article-title":"Hepatocellular and extrahepatic cancer in patients with autoimmune hepatitis: a long-term follow-up study in 634 Swedish patients","volume":"50","author":"Danielsson","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib97","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00535-012-0616-x","article-title":"Clinical features of hepatocellular carcinoma in patients with autoimmune hepatitis in Japan","volume":"48","author":"Ohira","year":"2013","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib98","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/hep.22432","article-title":"Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: implications for follow-up and screening","volume":"48","author":"Yeoman","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2015.08.012_bib99","first-page":"2115","article-title":"Reversal of liver cirrhosis in autoimmune hepatitis","volume":"58","author":"Shah","year":"2011","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.cgh.2015.08.012_bib100","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/apt.12592","article-title":"Review article: the prevention and reversal of hepatic fibrosis in autoimmune hepatitis","volume":"39","author":"Czaja","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2015.08.012_bib101","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/hep.24141","article-title":"Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis","volume":"53","author":"Yeoman","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2015.08.012_bib102","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1002\/hep.23924","article-title":"Application of the 2010 American Association for the study of liver diseases criteria of remission to a cohort of Italian patients with autoimmune hepatitis","volume":"52","author":"Muratori","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2015.08.012_bib103","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1007\/s10620-014-3267-3","article-title":"Low serum vitamin D levels are associated with severe histological features and poor response to therapy in patients with autoimmune hepatitis","volume":"59","author":"Efe","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2015.08.012_bib104","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1586\/egh.12.40","article-title":"Drug choices in autoimmune hepatitis: part A\u2014steroids","volume":"6","author":"Czaja","year":"2012","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000282071","article-title":"Therapeutic options to treat autoimmune hepatitis in 2009","volume":"28","author":"Strassburg","year":"2010","journal-title":"Dig Dis"},{"key":"10.1016\/j.cgh.2015.08.012_bib106","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.3748\/wjg.v9.i12.2681","article-title":"Side effects of budesonide in liver cirrhosis due to chronic autoimmune hepatitis: influence of hepatic metabolism versus portosystemic shunts on a patient complicated with HCC","volume":"9","author":"Geier","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib107","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jhep.2010.09.017","article-title":"Reactivation of autoimmune hepatitis during budesonide monotherapy, and response to standard treatment","volume":"54","author":"Lohse","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib108","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jhep.2010.01.037","article-title":"Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials","volume":"53","author":"Lamers","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib109","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/lt.21088","article-title":"Corticosteroids or not in severe acute or fulminant autoimmune hepatitis: therapeutic brinksmanship and the point beyond salvation","volume":"13","author":"Czaja","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2015.08.012_bib110","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/lt.21036","article-title":"Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis","volume":"13","author":"Ichai","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2015.08.012_bib111","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1542-3565(04)00246-0","article-title":"Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis","volume":"2","author":"Kessler","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"suppl 11","key":"10.1016\/j.cgh.2015.08.012_bib112","first-page":"278","article-title":"Fulminant autoimmune hepatitis type 1: clinical presentation, outcome and prognostic factors","volume":"5","author":"Villamil","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cgh.2015.08.012_bib113","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/hep.22894","article-title":"Liver failure as initial presentation of autoimmune hepatitis: clinical characteristics, predictors of response to steroid therapy, and outcomes","volume":"49","author":"Verma","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2015.08.012_bib114","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/FTD.0b013e3181dbd712","article-title":"Monitoring of azathioprine metabolites in pediatric patients with autoimmune hepatitis","volume":"32","author":"Nguyen","year":"2010","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.cgh.2015.08.012_bib115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1155\/2011\/137476","article-title":"Azathioprine metabolite measurements are not useful in following treatment of autoimmune hepatitis in Alaska Native and other non-Caucasian people","volume":"25","author":"Ferucci","year":"2011","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib116","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/s10620-006-9336-5","article-title":"Thiopurine methyltransferase deficiency and azathioprine intolerance in autoimmune hepatitis","volume":"51","author":"Czaja","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2015.08.012_bib117","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1007\/s10620-006-9119-z","article-title":"Thiopurine methyltransferase activity in Spain: a study of 14,545 patients","volume":"52","author":"Gisbert","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2015.08.012_bib118","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jhep.2006.05.011","article-title":"Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis","volume":"45","author":"Heneghan","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib119","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jhep.2009.10.004","article-title":"Characterisation and utility of thiopurine methyltransferase and thiopurine metabolite measurements in autoimmune hepatitis","volume":"52","author":"Hindorf","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib120","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/apt.12223","article-title":"Allopurinol safely and effectively optimises thiopurine metabolites in patients with autoimmune hepatitis","volume":"37","author":"de Boer","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2015.08.012_bib121","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/apt.12701","article-title":"Review article: permanent drug withdrawal is desirable and achievable for autoimmune hepatitis","volume":"39","author":"Czaja","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2015.08.012_bib122","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jhep.2012.09.009","article-title":"Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission","volume":"58","author":"van Gerven","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib123","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1478-3231.2007.01444.x","article-title":"Consequences of treatment withdrawal in type 1 autoimmune hepatitis","volume":"27","author":"Montano-Loza","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2015.08.012_bib124","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1080\/00365520601155266","article-title":"Autoimmune hepatitis among fertile women: strategies during pregnancy and breastfeeding?","volume":"42","author":"Werner","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib125","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S1590-8658(02)80098-6","article-title":"Spontaneous remission of autoimmune hepatitis during pregnancy","volume":"34","author":"Muratori","year":"2002","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2015.08.012_bib126","doi-asserted-by":"crossref","first-page":"J239","DOI":"10.1016\/j.jaut.2011.12.002","article-title":"Outcomes of pregnancy in women with autoimmune hepatitis","volume":"38","author":"Westbrook","year":"2012","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.cgh.2015.08.012_bib127","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/MCG.0b013e318176b8c5","article-title":"Follow-up of pregnant women with autoimmune hepatitis: the disease behavior along with maternal and fetal outcomes","volume":"43","author":"Terrabuio","year":"2009","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib128","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/j.1572-0241.2006.00538.x","article-title":"Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites","volume":"101","author":"de Boer","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib129","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S1542-3565(04)00245-9","article-title":"Severe autoimmune hepatitis first presenting in the early post partum period","volume":"2","author":"Samuel","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib130","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1440-1746.2010.06579.x","article-title":"Treatment of autoimmune hepatitis: a review of current and evolving therapies","volume":"26","author":"Jothimani","year":"2011","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib131","first-page":"326","article-title":"Deep cholestatic jaundice as the predominant manifestation in autoimmune hepatitis","volume":"57","author":"Wang","year":"2010","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.cgh.2015.08.012_bib132","article-title":"Clinical profile of primary biliary cirrhosis with features of autoimmune hepatitis: importance of corticosteroid therapy","author":"Yoshioka","year":"2013","journal-title":"Hepatol Res"},{"key":"10.1016\/j.cgh.2015.08.012_bib133","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1007\/s10620-008-0632-0","article-title":"Mycophenolate mofetil for autoimmune hepatitis: a single practice experience","volume":"54","author":"Wolf","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2015.08.012_bib134","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2036.2011.04727.x","article-title":"The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes","volume":"34","author":"Baven-Pronk","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2015.08.012_bib135","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1136\/gut.2007.122283","article-title":"IgG4 associated autoimmune hepatitis: a differential diagnosis for classical autoimmune hepatitis","volume":"56","author":"Umemura","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2015.08.012_bib136","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1478-3231.2009.02092.x","article-title":"Identification and characterization of IgG4-associated autoimmune hepatitis","volume":"30","author":"Chung","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2015.08.012_bib137","first-page":"55","article-title":"Autoimmune cholangitis associated to IgG4 related sclerosing disease","volume":"41","author":"Frider","year":"2011","journal-title":"Acta Gastroenterol Latinoam"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2015.08.012_bib138","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000341115","article-title":"Autoimmune hepatitis: new guidelines, new therapies","volume":"30","author":"Strassburg","year":"2012","journal-title":"Dig Dis"},{"key":"10.1016\/j.cgh.2015.08.012_bib139","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1586\/egh.09.15","article-title":"Current and future treatments of autoimmune hepatitis","volume":"3","author":"Czaja","year":"2009","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib140","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.gastro.2010.04.053","article-title":"Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis","volume":"139","author":"Czaja","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2015.08.012_bib141","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3748\/wjg.v16.i8.934","article-title":"Difficult treatment decisions in autoimmune hepatitis","volume":"16","author":"Czaja","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib142","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/MOG.0b013e3283457ce0","article-title":"Management of autoimmune hepatitis","volume":"27","author":"Mayo","year":"2011","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib143","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2036.2010.04241.x","article-title":"Review article: the modern management of autoimmune hepatitis","volume":"31","author":"Yeoman","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2015.08.012_bib144","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1517\/14656566.2011.524206","article-title":"Pharmacological management of autoimmune hepatitis","volume":"12","author":"Vergani","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.cgh.2015.08.012_bib145","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1586\/egh.12.38","article-title":"Drug choices in autoimmune hepatitis: part B\u2014nonsteroids","volume":"6","author":"Czaja","year":"2012","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib146","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/apt.12042","article-title":"Systematic review: managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs","volume":"36","author":"Selvarajah","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2015.08.012_bib147","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2174\/187152812803251006","article-title":"Nonstandard drugs and feasible new interventions for autoimmune hepatitis: part I","volume":"11","author":"Czaja","year":"2012","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1016\/j.cgh.2015.08.012_bib148","doi-asserted-by":"crossref","first-page":"e526","DOI":"10.1542\/peds.2011-1900","article-title":"Successful treatment of refractory autoimmune hepatitis with rituximab","volume":"132","author":"D'Agostino","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.cgh.2015.08.012_bib149","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/2013\/512624","article-title":"Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy","volume":"27","author":"Burak","year":"2013","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib150","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00228-011-1191-4","article-title":"Autoimmune hepatitis induced by adalimumab with successful switch to abatacept","volume":"68","author":"Grasland","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.cgh.2015.08.012_bib151","first-page":"133","article-title":"Autoimmune hepatitis 2013 and beyond","volume":"59","author":"Weiler-Normann","year":"2013","journal-title":"Minerva Gastroenterol Dietol"},{"key":"10.1016\/j.cgh.2015.08.012_bib152","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1097\/MPG.0b013e318291feaa","article-title":"Sirolimus as rescue therapy in pediatric autoimmune hepatitis","volume":"58","author":"Kurowski","year":"2014","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cgh.2015.08.012_bib153","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/hep.510300603","article-title":"Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial","volume":"30","author":"Czaja","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2015.08.012_bib154","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1053\/gast.2000.0010000001","article-title":"Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis","volume":"119","author":"Czaja","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2015.08.012_bib155","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0168-8278(98)80128-1","article-title":"Successful treatment of refractory type 1 autoimmune hepatitis with methotrexate","volume":"29","author":"Burak","year":"1998","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib156","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1111\/j.1572-0241.2001.05346.x","article-title":"Methotrexate therapy for refractory chronic active autoimmune hepatitis","volume":"96","author":"Venkataramani","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib157","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10620-005-1296-7","article-title":"Reversal of cirrhosis in a patient with primary biliary cirrhosis-autoimmune hepatitis overlap syndrome","volume":"50","author":"Vallone","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2015.08.012_bib158","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/157488611797579221","article-title":"Autoimmune hepatitis after long-term methotrexate therapy for rheumatoid arthritis","volume":"6","author":"Moreno-Otero","year":"2011","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.cgh.2015.08.012_bib159","doi-asserted-by":"crossref","first-page":"649","DOI":"10.4103\/0253-7613.144940","article-title":"Autoimmune hepatitis as an adverse effect of long-term methotrexate therapy","volume":"46","author":"Ksouda","year":"2014","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.cgh.2015.08.012_bib160","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1159\/000320410","article-title":"Hepatotoxicity of agents used in the management of inflammatory bowel disease","volume":"28","author":"Khokhar","year":"2010","journal-title":"Dig Dis"},{"key":"10.1016\/j.cgh.2015.08.012_bib161","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1155\/2010\/891252","article-title":"Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy","volume":"24","author":"Sharzehi","year":"2010","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib162","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cgh.2008.04.006","article-title":"A\u00a0single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis","volume":"6","author":"Hlivko","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib163","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/01.mcg.0000177260.72692.e8","article-title":"Empiric therapy of autoimmune hepatitis with mycophenolate mofetil: comparison with conventional treatment for refractory disease","volume":"39","author":"Czaja","year":"2005","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib164","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1478-3231.2005.01107.x","article-title":"Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus","volume":"25","author":"Chatur","year":"2005","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2015.08.012_bib165","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cgh.2007.02.030","article-title":"Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy","volume":"5","author":"Inductivo-Yu","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib166","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2174\/1568010023344526","article-title":"Emerging treatments for autoimmune hepatitis","volume":"1","author":"Czaja","year":"2002","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"10.1016\/j.cgh.2015.08.012_bib167","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S1089-3261(02)00029-6","article-title":"Evolving new therapies of autoimmune hepatitis","volume":"6","author":"Vierling","year":"2002","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cgh.2015.08.012_bib168","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.2174\/138161211798157568","article-title":"Promising pharmacological, molecular and cellular treatments of autoimmune hepatitis","volume":"17","author":"Czaja","year":"2011","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.cgh.2015.08.012_bib169","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1155\/2012\/512132","article-title":"Autoimmune hepatitis: focusing on treatments other than steroids","volume":"26","author":"Czaja","year":"2012","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib170","first-page":"771","article-title":"Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis\u2014results of an open-label preliminary trial","volume":"90","author":"Van Thiel","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib171","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/01.mcg.0000139050.67178.be","article-title":"Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis","volume":"38","author":"Aqel","year":"2004","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib172","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2036.2011.04749.x","article-title":"Use of tacrolimus in the treatment of autoimmune hepatitis: a single centre experience","volume":"34","author":"Tannous","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2015.08.012_bib173","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.3748\/wjg.v13.i23.3232","article-title":"Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis","volume":"13","author":"Larsen","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib174","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0168-8278(05)80615-4","article-title":"Cyclosporine in the management of corticosteroid-resistant type I autoimmune chronic active hepatitis","volume":"21","author":"Sherman","year":"1994","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib175","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1572-0241.1999.00807.x","article-title":"Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis","volume":"94","author":"Fernandes","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib176","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-2036.2003.01754.x","article-title":"Effectiveness and safety of ciclosporin as therapy for autoimmune diseases of the liver in children and adolescents","volume":"19","author":"Sciveres","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2015.08.012_bib177","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1023\/A:1010683817344","article-title":"Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis","volume":"46","author":"Malekzadeh","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2015.08.012_bib178","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.amjmed.2014.06.016","article-title":"Use of sirolimus in the treatment of refractory autoimmune hepatitis","volume":"127","author":"Chatrath","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.cgh.2015.08.012_bib179","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3109\/00365521.2014.998271","article-title":"Everolimus treatment for patients with autoimmune hepatitis and poor response to standard therapy and drug alternatives in use","volume":"50","author":"Ytting","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib180","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1600-6143.2005.00801.x","article-title":"Rapamycin successfully treats post-transplant autoimmune hepatitis","volume":"5","author":"Kerkar","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cgh.2015.08.012_bib181","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.transproceed.2011.05.028","article-title":"Effectiveness and safety of everolimus in the treatment of autoimmune hepatitis related to anti-hepatitis C virus therapy after liver transplant: three case reports","volume":"43","author":"Casanovas","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cgh.2015.08.012_bib182","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1478-3231.2006.01262.x","article-title":"Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature","volume":"26","author":"Santos","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2015.08.012_bib183","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1159\/000322693","article-title":"A\u00a0case of autoimmune hepatitis treated with rituximab","volume":"4","author":"Barth","year":"2010","journal-title":"Case Rep Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib184","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.4067\/S0034-98872011001100015","article-title":"Successful rituximab therapy in refractory autoimmune hepatitis and Evans syndrome","volume":"139","author":"Carey","year":"2011","journal-title":"Rev Med Chil"},{"key":"10.1016\/j.cgh.2015.08.012_bib185","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ajg.2013.08.009","article-title":"Rituximab for refractory autoimmune hepatitis: a case report","volume":"14","author":"Al-Busafi","year":"2013","journal-title":"Arab J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib186","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2012.11.010","article-title":"Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis","volume":"58","author":"Weiler-Normann","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib187","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2169\/internalmedicine.51.6824","article-title":"Adult-onset Still's disease complicated by autoimmune hepatitis: successful treatment with infliximab","volume":"51","author":"Fujii","year":"2012","journal-title":"Intern Med"},{"key":"10.1016\/j.cgh.2015.08.012_bib188","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11739-009-0342-4","article-title":"Infliximab-related hepatitis: discussion of a case and review of the literature","volume":"5","author":"Mancini","year":"2010","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.cgh.2015.08.012_bib189","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1007\/s10620-011-1748-1","article-title":"Infliximab-induced autoimmune hepatitis with successful switch to adalimumab in a patient with Crohn's disease: the index case","volume":"56","author":"Goldfeld","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2015.08.012_bib190","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.crohns.2012.01.017","article-title":"Autoimmune hepatitis following treatment with infliximab for inflammatory bowel disease","volume":"6","author":"van Casteren-Messidoro","year":"2012","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2015.08.012_bib191","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/ajd.12054","article-title":"Drug-induced lupus and autoimmune hepatitis secondary to infliximab for psoriasis","volume":"55","author":"Dang","year":"2014","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib192","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1097\/MCG.0b013e3181a745e7","article-title":"Adalimumab-induced autoimmune hepatitis","volume":"44","author":"Adar","year":"2010","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib193","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.autrev.2012.03.010","article-title":"Drug induced autoimmune hepatitis and TNF-alpha blocking agents: is there a real relationship?","volume":"12","author":"Efe","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cgh.2015.08.012_bib194","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/lt.22018","article-title":"Primary liver transplantation for autoimmune hepatitis: a comparative analysis of the European Liver Transplant Registry","volume":"16","author":"Schramm","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2015.08.012_bib195","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5582\/irdr.2014.01034","article-title":"Liver transplantation and autoimmune hepatitis","volume":"4","author":"Tanaka","year":"2015","journal-title":"Intractable Rare Dis Res"},{"key":"10.1016\/j.cgh.2015.08.012_bib196","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1007\/s10620-012-2179-3","article-title":"Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation","volume":"57","author":"Czaja","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2015.08.012_bib197","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1440-1746.2012.07125.x","article-title":"Impact of pretransplant antinuclear antibody and antismooth muscle antibody titers on disease recurrence and graft survival following liver transplantation in autoimmune hepatitis patients","volume":"28","author":"Dbouk","year":"2013","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib198","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1053\/jhep.2000.19149","article-title":"Recurrent autoimmune hepatitis after liver transplantation: when non-self becomes self","volume":"32","author":"Manns","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2015.08.012_bib199","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1053\/jlts.2002.33485","article-title":"Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance","volume":"8","author":"Czaja","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2015.08.012_bib200","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.4049\/jimmunol.173.9.5355","article-title":"Cutting edge: identification of hepatitis C virus-specific CD8+ T cells restricted by donor HLA alleles following liver transplantation","volume":"173","author":"Rosen","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.cgh.2015.08.012_bib201","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0168-8278(99)80017-8","article-title":"Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease","volume":"30","author":"Ratziu","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib202","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1432-2277.2008.00729.x","article-title":"Autoimmune liver diseases and recurrence after orthotopic liver transplantation: what have we learned so far?","volume":"22","author":"Schreuder","year":"2009","journal-title":"Transpl Int"},{"key":"10.1016\/j.cgh.2015.08.012_bib203","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/gut.52.6.893","article-title":"A\u00a010 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence","volume":"52","author":"Duclos-Vallee","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2015.08.012_bib204","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1053\/jhep.2000.9077","article-title":"Liver transplantation for autoimmune hepatitis: a long-term pathologic study","volume":"32","author":"Ayata","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2015.08.012_bib205","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/lt.20910","article-title":"Recurrence of autoimmune liver disease after liver transplantation: a systematic review","volume":"12","author":"Gautam","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2015.08.012_bib206","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00007890-199907270-00016","article-title":"Recurrence of autoimmune hepatitis after liver transplantation","volume":"68","author":"Milkiewicz","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.cgh.2015.08.012_bib207","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1053\/jlts.2001.24638","article-title":"Successful tacrolimus therapy for a severe recurrence of type 1 autoimmune hepatitis in a liver graft recipient","volume":"7","author":"Hurtova","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2015.08.012_bib208","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1053\/jlts.2001.21449","article-title":"Recurrent autoimmune hepatitis after orthotopic liver transplantation","volume":"7","author":"Gonzalez-Koch","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2015.08.012_bib209","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1432-2277.2007.00628.x","article-title":"The impact of disease recurrence on graft survival following liver transplantation: a single centre experience","volume":"21","author":"Rowe","year":"2008","journal-title":"Transpl Int"},{"key":"10.1016\/j.cgh.2015.08.012_bib210","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bpg.2011.09.008","article-title":"Liver transplantation in autoimmune liver diseases","volume":"25","author":"Ilyas","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib211","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-0031-1272834","article-title":"De novo autoimmune hepatitis after liver transplantation","volume":"31","author":"Guido","year":"2011","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cgh.2015.08.012_bib212","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(97)06478-7","article-title":"De-novo autoimmune hepatitis after liver transplantation","volume":"351","author":"Kerkar","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2015.08.012_bib213","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.26756","article-title":"Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults","volume":"34","author":"Heneghan","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2015.08.012_bib214","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.autrev.2010.12.009","article-title":"Alpha-actinin: a multidisciplinary protein with important role in B-cell driven autoimmunity","volume":"10","author":"Oikonomou","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cgh.2015.08.012_bib215","article-title":"Anti-phosphoenolpyruvate carboxykinase 2 antibody in patients with autoimmune hepatitis","author":"Kanno","year":"2013","journal-title":"Hepatol Res"},{"key":"10.1016\/j.cgh.2015.08.012_bib216","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/liv.12155","article-title":"Anti-ribosomal P protein: a novel antibody in autoimmune hepatitis","volume":"33","author":"Calich","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2015.08.012_bib217","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/hepr.12130","article-title":"Anti-nucleosome autoantibodies as markers for autoimmune hepatitis and their correlation with disease activity","volume":"44","author":"Yokokawa","year":"2014","journal-title":"Hepatol Res"},{"key":"10.1016\/j.cgh.2015.08.012_bib218","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/jgh.12340","article-title":"Anti-programmed cell death-1 antibody as a new serological marker for type 1 autoimmune hepatitis","volume":"29","author":"Matsumoto","year":"2014","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2015.08.012_bib219","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1074\/mcp.M112.018713","article-title":"Identification of new autoantigens by protein array indicates a role for IL4 neutralization in autoimmune hepatitis","volume":"11","author":"Zingaretti","year":"2012","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.cgh.2015.08.012_bib220","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1345\/aph.1H136","article-title":"Nitrofurantoin-induced fulminant hepatitis mimicking autoimmune hepatitis","volume":"40","author":"Peedikayil","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.cgh.2015.08.012_bib221","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/00004836-200609000-00018","article-title":"Autoimmune hepatitis triggered by statins","volume":"40","author":"Alla","year":"2006","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2015.08.012_bib222","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12016-014-8432-0","article-title":"Emperipolesis mediated by CD8 T cells is a characteristic histopathologic feature of autoimmune hepatitis","volume":"48","author":"Miao","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.cgh.2015.08.012_bib223","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3748\/wjg.v21.i1.60","article-title":"Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics","volume":"21","author":"Gatselis","year":"2015","journal-title":"World J Gastroenterol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356515011118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356515011118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:21:35Z","timestamp":1761542495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356515011118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":223,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S1542356515011118"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2015.08.012","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune Hepatitis and Overlap Syndromes: Diagnosis and Management","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2015.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}